Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Although cellular senescence may be a protective mechanism in modulating proliferative capacity, fibroblast senescence is now recognized as a key pathogenic mechanism in idiopathic pulmonary fibrosis (IPF). In aged mice, abundance and persistence of apoptosis-resistant senescent fibroblasts play a central role in nonresolving lung fibrosis after bleomycin challenge. Therefore, we investigated whether quercetin can restore the susceptibility of senescent IPF fibroblasts to proapoptotic stimuli and mitigate bleomycin-induced pulmonary fibrosis in aged mice. Unlike senescent normal lung fibroblasts, IPF lung fibroblasts from patients with stable and rapidly progressing disease were highly resistant to Fas ligand (FasL)-induced and TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Senescent IPF fibroblasts exhibited decreased expression of FasL and TRAIL receptors and caveolin-1, as well as increased AKT activation, compared with senescent normal lung fibroblasts. Although quercetin alone was not proapoptotic, it abolished the resistance to FasL- or TRAIL-induced apoptosis in IPF fibroblasts. Mechanistically, quercetin upregulated FasL receptor and caveolin-1 expression and modulated AKT activation. In vivo quercetin reversed bleomycin-induced pulmonary fibrosis and attenuated lethality, weight loss, and the expression of pulmonary senescence markers p21 and p19-ARF and senescence-associated secretory phenotype in aged mice. Collectively, these data indicate that quercetin reverses the resistance to death ligand-induced apoptosis by promoting FasL receptor and caveolin-1 expression and inhibiting AKT activation, thus mitigating the progression of established pulmonary fibrosis in aged mice. Therefore, quercetin may be a viable therapeutic option for IPF and other age-related diseases that progress with the accumulation of senescent fibroblasts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Preclinical evidence suggests that senescent fibroblasts and alveolar epithelial cells contribute to pulmonary fibrosis and supports cellular senescence as a potential target for treatment for bleomycin-induced lung injury model of pulmonary fibrosis that may be translationally relevant to humans.5,10,11”
From Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability (2023) · cites this paper as [10]
Experimental — accuracy not yet measuredIn the citing paper
“In bleomycin-induced pulmonary fibrosis models, monotherapy with quercetin markedly reduced senescent markers.10”
In the citing paper
“Augmentation of endogenous Cav-1 levels and supplementation of exogenous caveolin scaffolding domain (CSD) peptide have been shown to suppress lung fibrosis7,10,11,13,14.”
From Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study (2026) · cites this paper as [13]
Citations
Cites
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y.-S., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,258
Health effects of quercetin: From antioxidant to nutraceutical
Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.008 · Cited by 2,121
Cellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Apo2L/TRAIL and its death and decoy receptors
LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 854
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805
PI 3-kinase, Akt and cell survival
Downward, J. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.01.002 · Cited by 783
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance
Hecker, L., Logsdon, N. J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y. Y., & Thannickal, V. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008182 · Cited by 686
Research works printed but not linked: 1
- Pechkovsky, 2012, Fibroblast senescence in UIP/IPF: a contributing factor or consequence of the disease? [abstract], Am J Respir Crit Care Med, 185, A5282
Cited by
Wound healing: cellular mechanisms and pathological outcomes
Wilkinson, H. N., & Hardman, M. J. (2020) · Open Biology · doi:10.1098/rsob.200223 · Cited by 1,796
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614
Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases
Barnes, P. J., Baker, J., & Donnelly, L. E. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1975tr · Cited by 555
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Wang, J., Hu, K., Cai, X., Yang, B., He, Q., Wang, J., & Weng, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.023 · Cited by 450
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
Mei, Q., Liu, Z., Zuo, H., Yang, Z., & Qu, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.797292 · Cited by 360
Nambiar, A., Kellogg, D., Justice, J., Goros, M., Gelfond, J., Pascual, R., Hashmi, S., Masternak, M., Prata, L., LeBrasseur, N., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104481 · Cited by 298
Han, Y., & Kim, S. Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00906-w · Cited by 201
Pharmacological Activity of Quercetin: An Updated Review
Wang, G., Wang, Y., Yao, L., Gu, W., Zhao, S., Shen, Z., Lin, Z., Liu, W., & Yan, T. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3997190 · Cited by 224
Liu, T., Yang, Q., Zhang, X., Qin, R., Shan, W., Zhang, H., & Chen, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118116 · Cited by 169
Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)
Saito, S., Alkhatib, A., Kolls, J. K., Kondoh, Y., & Lasky, J. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.04.62 · Cited by 148
Summer, R., Shaghaghi, H., Schriner, D., Roque, W., Sales, D., Cuevas-Mora, K., Desai, V., Bhushan, A., Ramirez, M. I., & Romero, F. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00244.2018 · Cited by 143
Liu, H., Xu, Q., Wufuer, H., Li, Z., Sun, R., Jiang, Z., Dou, X., Fu, Q., Campisi, J., & Sun, Y. (2023) · Aging Cell · doi:10.1111/acel.13921 · Cited by 146
Mechanisms for the Resolution of Organ Fibrosis
Horowitz, J. C., & Thannickal, V. J. (2018) · Physiology · doi:10.1152/physiol.00033.2018 · Cited by 144
Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis
Parimon, T., Hohmann, M. S., & Yao, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126214 · Cited by 134
Self-citationSenotherapeutics: targeting senescence in idiopathic pulmonary fibrosis
Merkt, W., Bueno, M., Mora, A. L., & Lagares, D. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.008 · Cited by 119
Han, D., Gong, H., Wei, Y., Xu, Y., Zhou, X., Wang, Z., & Feng, F. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154680 · Cited by 134
Veith, C., Boots, A. W., Idris, M., van Schooten, F., & van der Vliet, A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7742 · Cited by 119
Cellular senescence in the lung across the age spectrum
Parikh, P., Wicher, S., Khandalavala, K., Pabelick, C. M., Britt, R. D., & Prakash, Y. S. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00424.2018 · Cited by 112
Fibroblast Senescence in Idiopathic Pulmonary Fibrosis
Lin, Y., & Xu, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593283 · Cited by 115
Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging
Kato, K., Logsdon, N. J., Shin, Y.-J., Palumbo, S., Knox, A., Irish, J. D., Rounseville, S. P., Rummel, S. R., Mohamed, M., Ahmad, K., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0092oc · Cited by 113
Senescence of alveolar epithelial progenitor cells: a critical driver of lung fibrosis
Parimon, T., Chen, P., Stripp, B. R., Liang, J., Jiang, D., Noble, P. W., Parks, W. C., & Yao, C. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00239.2023 · Cited by 110
The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype
Mebratu, Y. A., Soni, S., Rosas, L., Rojas, M. M., Horowitz, J. C., & Nho, R. S. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00124.2023 · Cited by 103
Cellular Senescence: The Trojan Horse in Chronic Lung Diseases
Hamsanathan, S., Alder, J. K., Sellares, J., Rojas, M., Gurkar, A. U., & Mora, A. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0410tr · Cited by 86
Cellular Senescence: Mechanisms and Therapeutic Potential
Liao, Z., Yeo, H. L., Wong, S. W., & Zhao, Y. X. (2021) · Biomedicines · doi:10.3390/biomedicines9121769 · Cited by 94
Loss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis
Chin, C., Ravichandran, R., Sanborn, K., Fleming, T. P., Wheatcroft, S. B., Kearney, M. T., Tokman, S., Walia, R., Smith, M. A., Flint, D. J., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100945 · Cited by 106
NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis
Kato, K., & Hecker, L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101541 · Cited by 71
The role of natural products in the prevention and treatment of pulmonary fibrosis: a review
Wang, L., Li, S., Yao, Y., Yin, W., & Ye, T. (2020) · Food & Function · doi:10.1039/d0fo03001e · Cited by 69
Cellular Senescence in Idiopathic Pulmonary Fibrosis
Kellogg, D. L., Kellogg, D. L., Musi, N., & Nambiar, A. M. (2021) · Current Molecular Biology Reports · doi:10.1007/s40610-021-00145-4 · Cited by 67
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
Korfei, M., Mahavadi, P., & Guenther, A. (2022) · Cells · doi:10.3390/cells11101626 · Cited by 72
Khalil, A., & Tazeddinova, D. (2020) · Natural Products and Bioprospecting · doi:10.1007/s13659-020-00271-z · Cited by 73
Pulmonary fibrosis: Therapeutic and mechanistic insights into the role of phytochemicals
Hosseini, S. A., Zahedipour, F., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021) · BioFactors · doi:10.1002/biof.1713 · Cited by 64
Fight to the bitter end: DNA repair and aging
Chen, Y., Geng, A., Zhang, W., Qian, Z., Wan, X., Jiang, Y., & Mao, Z. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101154 · Cited by 61
Wang, J., Wu, Q., Ding, L., Song, S., Li, Y., Shi, L., Wang, T., Zhao, D., Wang, Z., & Li, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.734450 · Cited by 71
Mbara, K. C., Devnarain, N., & Owira, P. M. O. (2022) · Pharmaceutical Medicine · doi:10.1007/s40290-022-00444-w · Cited by 47
The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice
Boots, A. W., Veith, C., Albrecht, C., Bartholomé, R., Drittij-Reijnders, M.-J., Claessen, S. M. H., Bast, A., Rosenbruch, M., Jonkers, L., van Schooten, F., et al. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-1142-x · Cited by 64
Zhang, L., Tong, X., Huang, J., Wu, M., Zhang, S., Wang, D., Liu, S., & Fan, H. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.553690 · Cited by 60
Merkt, W., Zhou, Y., Han, H., & Lagares, D. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12952 · Cited by 69
Xu, J., Gao, L., Liang, H., & Chen, S. (2020) · Nutrition · doi:10.1016/j.nut.2020.111049 · Cited by 52
Xiao, Y., Zhou, L., Zhang, T., Qin, C., Wei, P., Luo, L., Luo, L., Huang, G., Chen, A., & Liu, G. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117552 · Cited by 54
Senescence in Pulmonary Fibrosis: Between Aging and Exposure
Venosa, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606462 · Cited by 54
Wang, Q., Wang, F., Li, X., Ma, Z., & Jiang, D. (2022) · Phytotherapy Research · doi:10.1002/ptr.7599 · Cited by 56
Yuan, J.-H., Ma, Y., Yuan, L.-H., Gong, J., Xu, L., Wang, L.-V., & Jin, Y. (2023) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2160767 · Cited by 43
Cellular senescence is increased in airway smooth muscle cells of elderly persons with asthma
Aghali, A., Khalfaoui, L., Lagnado, A. B., Drake, L. Y., Teske, J. J., Pabelick, C. M., Passos, J. F., & Prakash, Y. S. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00146.2022 · Cited by 44
Wang, X., Zhao, S., Lai, J., Guan, W., & Gao, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010099 · Cited by 42
Role of cellular senescence in the pathogenesis of systemic sclerosis
Tsou, P., Shi, B., & Varga, J. (2022) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000898 · Cited by 44
Korfei, M., MacKenzie, B., & Meiners, S. (2020) · European Respiratory Review · doi:10.1183/16000617.0126-2020 · Cited by 45
Senescence-mediated anticancer effects of quercetin
Özsoy, S., Becer, E., & Vatansever, H. S. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.04.007 · Cited by 45
Targeting defective pulmonary innate immunity – A new therapeutic option?
Belchamber, K. B. R., & Donnelly, L. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107500 · Cited by 41
Wu, W., Wu, X., Qiu, L., Wan, R., Zhu, X., Chen, S., Xinying, Y., Liu, X., & Wu, J. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02913-8 · Cited by 41
Chu, L., Zhuo, J., Huang, H., Chen, W., Zhong, W., Zhang, J., Meng, X., Zou, F., Cai, S., Zou, M., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176459 · Cited by 44
Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis
Wang, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19308 · Cited by 36
Context‐dependent roles of cellular senescence in normal, aged, and disease states
Moiseeva, V., Cisneros, A., Cobos, A. C., Tarrega, A. B., Oñate, C. S., Perdiguero, E., Serrano, A. L., & Muñoz‐Cánoves, P. (2023) · The FEBS Journal · doi:10.1111/febs.16573 · Cited by 34
Role of cellular senescence in inflammatory lung diseases
Xie, C. H., Yalikun, M., Luo, Q., & Dong, J. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.02.001 · Cited by 33
p53 and Myofibroblast Apoptosis in Organ Fibrosis
McElhinney, K., Irnaten, M., & O'Brien, C. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076737 · Cited by 39
Russo, M., Moccia, S., Luongo, D., & Russo, G. L. (2023) · Cancers · doi:10.3390/cancers15092660 · Cited by 35
Mercader, J., Truyols-Vives, J., Río, C., López-Safont, N., Sala, E., & Chaplin, A. M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176051 · Cited by 36
Recent developments in the pathobiology of lung myofibroblasts
Jiang, D., Dey, T., & Liu, G. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1829972 · Cited by 36
Airway Epithelium Senescence as a Driving Mechanism in COPD Pathogenesis
Bateman, G., Guo-Parke, H., Rodgers, A. M., Linden, D. A., Bailey, M., Weldon, S., Kidney, J. C., & Taggart, C. C. (2023) · Biomedicines · doi:10.3390/biomedicines11072072 · Cited by 44
Cellular Senescence: A Troy Horse in Pulmonary Fibrosis
Wan, R., Wang, L., Zhu, M., Li, W., Duan, Y., & Yu, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216410 · Cited by 36
Cheng, D., Lian, W., Jia, X., Wang, T., Sun, W., Liu, Y., & Ni, C. (2024) · Toxicology · doi:10.1016/j.tox.2024.153962 · Cited by 32
PI3K/Akt in IPF: untangling fibrosis and charting therapies
Bhatt, J., Ghigo, A., & Hirsch, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1549277 · Cited by 41
Update in Interstitial Lung Disease 2019
Montesi, S. B., Fisher, J. H., Martínez, F. J., Selman, M., Pardo, A., & Johannson, K. A. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0360up · Cited by 37
Fibroblasts and their responses to chronic injury in pulmonary fibrosis
Wu, B., Tang, L. F., & Kapoor, M. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.12.003 · Cited by 37
Advances in cellular senescence in idiopathic pulmonary fibrosis (Review)
Han, S., Lu, Q., & Liu, X. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11844 · Cited by 34
Qin, S., Tan, P., Xie, J., Zhou, Y., & Zhao, J. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00797-7 · Cited by 34
Flavonoids for treating pulmonary fibrosis: Present status and future prospects
Sharma, A., & Wairkar, S. (2024) · Phytotherapy Research · doi:10.1002/ptr.8285 · Cited by 30
Chen, L., Alam, A., Soo, A. P., Chen, Q., Shang, Y., Zhao, H., Yao, S., & Ma, D. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00617-2 · Cited by 30
Functional Pdgfra fibroblast heterogeneity in normal and fibrotic mouse lung
Trempus, C. S., Papas, B. N., Sifre, M. I., Bortner, C. D., Scappini, E., Tucker, C. J., Xu, X., Johnson, K. L., Deterding, L. J., Williams, J. G., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.164380 · Cited by 34
Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment
Zhang, T., Zhang, J., Lv, C., Li, H., & Song, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1059434 · Cited by 29
Bientinesi, E., Ristori, S., Lulli, M., & Monti, D. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111957 · Cited by 26
Cao, Y., Chen, H., Sun, Y. L., Fan, Z., & Cheng, H. H. (2022) · Bioengineered · doi:10.1080/21655979.2022.2062530 · Cited by 26
Tu, M., Wei, T., Jia, Y., Wang, Y., & Wu, J. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-22-886 · Cited by 29
The critical roles of caveolin-1 in lung diseases
Fan, J., Zheng, S., Wang, M., & Yuan, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1417834 · Cited by 21
Habiel, D. M., Hohmann, M. S., Espíndola, M. S., Coelho, A. L., Jones, I. C., Jones, H. D., Carnibella, R. P., Pinar, I. P., Werdiger, F., & Hogaboam, C. M. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0922-7 · Cited by 22
Self-citationNelkine, L., Vrolijk, M. F., Drent, M., & Bast, A. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000684 · Cited by 23
Quercetin in Idiopathic Pulmonary Fibrosis: Another Brick in the Senolytic Wall
Sellarés, J., & Rojas, M. M. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0267ed · Cited by 22
Cellular and molecular features of senescence in acute lung injury
Huidobro, C., Martín-Vicente, P., López‐Martínez, C., López-Alonso, I., Amado‐Rodríguez, L., Crespo, I., & Albaiceta, G. M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111410 · Cited by 20
Zhang, R., Wen, Y., Liu, J., Hao, J., Peng, Y., Zhang, M., Xie, Y., Yang, Z., Yin, X., Shi, Y., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05523-x · Cited by 21
New Trends in Aging Drug Discovery
Benhamú, B., Martín‐Fontecha, M., Vázquez‐Villa, H., López-Rodríguez, M. L., & Ortega‐Gutiérrez, S. (2022) · Biomedicines · doi:10.3390/biomedicines10082006 · Cited by 22
Zhu, D., Yu, Q., Sun, J., & Shen, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.733618 · Cited by 19
Lao, Q., Wang, X., Zhu, G., Yuan, H., Ma, T., & Wang, N. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1329743 · Cited by 18
Li, Z., Jiao, Y., Wu, Z., Liu, H., Li, Y., Cai, Y., Wei, W., & Cao, F. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09752-7 · Cited by 21
Targeting cellular senescence to combat cancer and ageing
Wang, C., Hao, X., & Zhang, R. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13266 · Cited by 21
Chávez‐Galán, L., Becerril, C., Ruíz, A., Ramón‐Luing, L. A., Cisneros, J., Montaño, M., Salgado-Aguayo, A. R., Ramos, C., Buendía-Roldán, I., Pardo, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.820347 · Cited by 20
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
Zeng, Q., Zhou, T., Huang, W., Huang, X., Huang, L., Zhang, X., Sang, X., Luo, Y.-Y., Tian, Y., Wu, B., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-41933-5 · Cited by 21
Yang, C., Xu, T., Lu, Y., Liu, J., Chen, C., Wang, H., & Chen, X. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.028 · Cited by 20
Wang, Y., He, X., Wang, H., Hu, W., & Sun, L. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117820 · Cited by 17
Chen, J., Li, G., He, X., Chen, Z., Chen, Z., Liu, D., Guo, S., Huang, T., Lan, P., Lan, P., et al. (2023) · Gastroenterology report · doi:10.1093/gastro/goae045 · Cited by 18
Role of ACE2-Ang (1–7)-Mas axis in post-COVID-19 complications and its dietary modulation
Sahu, S., Patil, C. R., Kumar, S., Apparsundaram, S., & Goyal, R. K. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04275-2 · Cited by 18
Souid, I., Korchef, A., & Souid, S. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.02.014 · Cited by 18
A model of the aged lung epithelium in idiopathic pulmonary fibrosis
Shaghaghi, H., Cuevas-Mora, K., Para, R., Tran, C., Roque, W., Robertson, M. J., Rosas, I. O., Summer, R. S., & Romero, F. (2021) · Aging · doi:10.18632/aging.203291 · Cited by 14
Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology
Qiang, R., Zhang, Y., & Wang, Y. (2022) · Disease Markers · doi:10.1155/2022/8925637 · Cited by 14
Wang, S., Qiao, J., Jiang, C., Pan, D., Yu, S., Chen, J., Liu, S., Zhang, P., Zhao, D., & Liu, M. (2023) · Antioxidants · doi:10.3390/antiox12020296 · Cited by 18
Zhang, Y., Jiang, W., Xia, Q., Jia, Q., & Cao, M. (2019) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2019.101003 · Cited by 14
The therapeutic mechanisms of quercetin on inflammatory diseases: an update
Xu, J., Hu, H., Jiang, H., Wei, Q., Zhang, H., & Lu, Q. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01795-x · Cited by 19
Gao, A. Y., Espinosa, A. M. D., Gianì, F., Pham, T. X., Carver, C. M., Aravamudhan, A., Bartman, C. M., Ligresti, G., Caporarello, N., Schafer, M. J., et al. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00023.2022 · Cited by 18
Hou, Y., Wang, G., Shuo, H., Liu, H., & Jia, X. (2023) · Medicine · doi:10.1097/md.0000000000033729 · Cited by 13
Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies
Dey, A. K., Banarjee, R., Boroumand, M., Rutherford, D. V., Strassheim, Q., Nyunt, T., Olinger, B., & Basisty, N. (2023) · Biology · doi:10.3390/biology12101301 · Cited by 14
Lettieri, S., Bertuccio, F. R., Frate, L. D., Perrotta, F., Corsico, A. G., & Stella, G. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010547 · Cited by 17
Metadata
- Authors
- Hohmann, M. S., Habiel, D. M., Coelho, A. L., Verri, W. A., & Hogaboam, C. M.
- Affiliations
- Universidade Estadual de Londrina (BR)
- Cedars-Sinai Medical Center (US)
- Departmento de Ciências Patológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brasil; and
- Corresponding author
- Hogaboam, Cory M.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-01
- Volume
- 60
- Issue
- 1
- Pages
- 28-40
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC6348716
- OpenAlex
- W2885632389
- Cited by
- 202
- References
- 46
- Citations by year
- 2026: 17 · 2025: 28 · 2024: 32 · 2023: 39 · 2022: 27 · 2021: 19 · 2020: 24 · 2019: 13
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- National Institutes of Health (NIH-R01, R01‐grant, HL123899)
- National Heart, Lung, and Blood Institute (R01HL123899)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- quercetin, idiopathic pulmonary fibrosis, cellular senescence, fibroblast senescence, apoptosis resistance, Fas ligand, TRAIL, caveolin-1, Akt activation, senescence-associated secretory phenotype, bleomycin-induced lung fibrosis, aged mice, p21, antifibrotic therapy
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Antioxidants, Bleomycin, Female, Fibroblasts, Humans, Male, Mice, Inbred C57BL, Quercetin, Cellular Senescence, Apoptosis, Mice, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.